1-benzhydrylpiperidin-4-one | 57391-13-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-benzhydrylpiperidin-4-one
• 英文别名: N-(diphenylmethyl)4-piperidone
• CAS: 57391-13-6
• 化学式: C₁₈H₁₉NO
• 分子量: 265.355
• InChiKey: QLWJYOLYCKTBQT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  1-benzhydrylpiperidin-4-one 在 sodium hydride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 生成 1-Benzhydryl-4-phenyl-4-propoxypiperidine
  参考文献：
  名称：

  Synthesis and structure–activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1

  摘要：

  A series of 4-hydroxy-4-phenylpiperidines have been synthesized and bind to the nociceptin receptor with high affinity. The synthesis and structure-activity relationships at the N-1 and C-4 are described. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.03.061
• 作为产物：
  描述：

  4-氧代哌啶酮盐酸盐 、 二苯基溴甲烷 在 potassium carbonate 作用下， 以 水 、 乙腈 为溶剂， 生成 1-benzhydrylpiperidin-4-one
  参考文献：
  名称：

  Synthesis and structure–activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2

  摘要：

  A series of 4-[2-(aminomethyl)phenyl]-1-[bis(2-chlorophenyl)methyl]-4-hydroxypiperidine analogs has been identified as nociceptin receptor ligands. These compounds display high affinity and functional activity at the nociceptin receptor. The synthesis and structure-activity relationships at the C-4 phenyl and N-1 positions are described and the antitussive activity of a selected compound is reported. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.03.062

文献信息

• Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
  申请人：Klinge Pharma GmbH

  公开号：US06451816B1

  公开（公告）日：2002-09-17

  The invention relates to the use of pharmacologically valuable pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides according to general formula (I) in the treatment of tumors or for immunosuppression.

  该发明涉及根据通式(I)中的具有药理学价值的吡啶基烷、吡啶基烯和/或吡啶基炔酸酰胺在肿瘤治疗或免疫抑制中的使用。
• Pyridyl alkane acid amides as cytostatics and immunosupressives
  申请人：Klinge Pharma GmbH

  公开号：US20030162972A1

  公开（公告）日：2003-08-28

  The invention relates to new pyridyl alkane acid amides according to general formula (I) as well as methods for their production, medicaments containing these compounds as well as their medical use, especially in the treatment of tumors or for immunosuppression. 1

  该发明涉及按照通式（I）的新吡啶基烷基酸酰胺，以及其生产方法，含有这些化合物的药物以及它们在医学上的应用，特别是在肿瘤治疗或免疫抑制方面的用途。
• Pyridyl alkane acid amides as cytostatics and immunosuppressives
  申请人：Klinge Pharma GmbH

  公开号：US06444823B1

  公开（公告）日：2002-09-03

  The invention relates to new pyridyl alkane acid amides according to general formula (I) as well as methods for their production, medicaments containing these compounds as well as their medical use, especially in the treatment of tumors or for immunosuppression.

  该发明涉及按照一般式（I）的新吡啶基烷基酸酰胺，以及其生产方法，含有这些化合物的药物以及它们在医学上的用途，特别是在肿瘤治疗或免疫抑制方面的用途。
• New pyridyl alkane acid amides as cytostatics and immunosuppressives
  申请人：Klinge Pharma GmbH

  公开号：US20040176605A1

  公开（公告）日：2004-09-09

  The invention relates to new pyridyl alkane acid amides according to general formula (I) as well as methods for their production, medicaments containing these compounds as well as their medical use, especially in the treatment of tumors or for immunosuppression. 1

  该发明涉及一种新的吡啶基烷基酸酰胺，其通用式为（I），以及其制备方法，含有这些化合物的药物以及它们在医学上的应用，特别是在肿瘤治疗或免疫抑制方面的应用。1
• [EN] PRODRUGS FOR SUSTAINED RELEASING THERAPEUTIC AGENTS AND USES THEREOF<br/>[FR] PROMÉDICAMENTS POUR AGENTS THÉRAPEUTIQUES À LIBÉRATION PROLONGÉE ET LEURS UTILISATIONS
  申请人：LIANGJIANG MEDICINE CO LTD

  公开号：WO2022083679A1

  公开（公告）日：2022-04-28

  Provided are prodrugs for sustained releasing therapeutic agents, and methods for using such prodrugs for the treatment of diseases.

  提供了用于缓释治疗剂的前药，以及使用这种前药治疗疾病的方法。